GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Gross Margin %

Consun Pharmaceutical Group (HKSE:01681) Gross Margin % : 73.81% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Consun Pharmaceutical Group's Gross Profit for the six months ended in Dec. 2023 was HK$1,187 Mil. Consun Pharmaceutical Group's Revenue for the six months ended in Dec. 2023 was HK$1,608 Mil. Therefore, Consun Pharmaceutical Group's Gross Margin % for the quarter that ended in Dec. 2023 was 73.81%.


The historical rank and industry rank for Consun Pharmaceutical Group's Gross Margin % or its related term are showing as below:

HKSE:01681' s Gross Margin % Range Over the Past 10 Years
Min: 72.99   Med: 74.89   Max: 80.68
Current: 74.19


During the past 12 years, the highest Gross Margin % of Consun Pharmaceutical Group was 80.68%. The lowest was 72.99%. And the median was 74.89%.

HKSE:01681's Gross Margin % is ranked better than
87.92% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs HKSE:01681: 74.19

Consun Pharmaceutical Group had a gross margin of 73.81% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Consun Pharmaceutical Group was 0.10% per year.


Consun Pharmaceutical Group Gross Margin % Historical Data

The historical data trend for Consun Pharmaceutical Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Gross Margin % Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.99 75.40 74.70 75.35 74.19

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.78 74.29 76.13 74.70 73.81

Competitive Comparison of Consun Pharmaceutical Group's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Gross Margin % falls into.



Consun Pharmaceutical Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Consun Pharmaceutical Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=2101.9 / 2833.013
=(Revenue - Cost of Goods Sold) / Revenue
=(2833.013 - 731.122) / 2833.013
=74.19 %

Consun Pharmaceutical Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1187 / 1608.332
=(Revenue - Cost of Goods Sold) / Revenue
=(1608.332 - 421.295) / 1608.332
=73.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Consun Pharmaceutical Group  (HKSE:01681) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Consun Pharmaceutical Group had a gross margin of 73.81% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Consun Pharmaceutical Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Executives
An Yubao 2101 Beneficial owner
Li Qian 2101 Beneficial owner
Central Success Developments Limited 2101 Beneficial owner
Aali Resources Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2301 Trustee
Zhang Lihua 2202 Interest of your spouse
An Meng 2101 Beneficial owner
Double Grace International Limited 2101 Beneficial owner
Bos Trustee Limited As Trustee 2201 Interest of corporation controlled by you

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines